Innovative methodology for the identification of soluble biomarkers in fresh tissues.

about

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

Item

http://www.wikidata.org/entity/Q51734150

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@en

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@nl

type

Item

label

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@en

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@nl

prefLabel

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@en

Innovative methodology for the identification of soluble biomarkers in fresh tissues.

@nl

P1476

Innovative methodology for the identification of soluble biomarkers in fresh tissues

@en

P2093

Akeila Bellahcène

http://www.w3.org/2001/XMLSchema#string

Alain Colige

http://www.w3.org/2001/XMLSchema#string

Andrei Turtoi

http://www.w3.org/2001/XMLSchema#string

Benjamin Koopmansch

http://www.w3.org/2001/XMLSchema#string

Carla Coimbra

http://www.w3.org/2001/XMLSchema#string

Dominique Baiwir

http://www.w3.org/2001/XMLSchema#string

Edouard Louis

http://www.w3.org/2001/XMLSchema#string

Eugene Mutijima

http://www.w3.org/2001/XMLSchema#string

Jacques Boniver

http://www.w3.org/2001/XMLSchema#string

Karim Fahmy

http://www.w3.org/2001/XMLSchema#string

P2860

Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach

TM4 microarray software suite

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.

Mass spectrometric proteomics profiles of in vivo tumor secretomes: capillary ultrafiltration sampling of regressive tumor masses.

Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.

Circulating tumor DNA as a liquid biopsy for cancer.

Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data.

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

P304

10665-10680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24366

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535834

http://www.w3.org/2001/XMLSchema#string

P932

5828218

http://www.w3.org/2001/XMLSchema#string